Cargando…
Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats
OBJECTIVE: Fluorophore-labeled contrast imaging agents are moving toward clinical use for a number of applications. The near-infrared dye IRDye 800CW is frequently used in its N-hydroxysuccinamide (NHS) ester form for labeling these agents. Following conjugation or breakdown of a labeled ligand, exc...
Autores principales: | Marshall, Milton V., Draney, Daniel, Sevick-Muraca, Eva M., Olive, D. Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978892/ https://www.ncbi.nlm.nih.gov/pubmed/20376568 http://dx.doi.org/10.1007/s11307-010-0317-x |
Ejemplares similares
-
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018) -
Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022) -
Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW
por: Krishnan, Giri, et al.
Publicado: (2021) -
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
por: Bernhard, Wendy, et al.
Publicado: (2021) -
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
por: Cohen, Ruth, et al.
Publicado: (2011)